Progress in stem cell-based therapy for liver disease.

Area of Science:

• Regenerative Medicine
• Hepatology
• Stem Cell Biology

Background:

• Liver transplantation is limited by donor organ scarcity, necessitating alternative treatments for end-stage liver disease.
• Advances in stem cell biology provide new therapeutic avenues for acute and chronic liver failure.
• Stem cells' proliferative and differentiation capacities are ideal for cell-based liver regeneration.

Purpose of the Study:

• To review and analyze recent clinical trials on stem cell therapy for liver disease.
• To assess the potential of various stem cell types in liver regeneration.
• To provide a perspective on stem cell-based therapeutic approaches for liver conditions.

Main Methods:

• Review of clinical trial reports on stem cell therapy for liver disease.
• Inclusion of studies using mesenchymal stem cells, hematopoietic stem cells, bone marrow mononuclear cells, and liver progenitor cells.
• Analysis of trial design, cell types, patient demographics, and therapeutic efficacy.

Main Results:

• Multiple stem cell types demonstrate significant potential for liver regeneration in preclinical studies.
• Clinical trial reports exhibit heterogeneity in design, cell infusion, patient populations, and outcomes.
• Identified stem cell sources include mesenchymal stem cells, hematopoietic stem cells, liver progenitor cells, and bone marrow mononuclear cells.

Conclusions:

• Stem cell therapy holds considerable promise as an alternative to liver transplantation.
• Further standardization and rigorous evaluation of clinical trials are needed to establish efficacy.
• This review offers insights into current stem cell-based strategies for managing liver disease.